Evidence map›Paper›PMID 22352414›Full record

ArticleJournal of the American Geriatrics Society2012

All-cause 1-, 5-, and 10-year mortality in elderly people according to activities of daily living stage.

Margaret G Stineman, Dawei Xie, Qiang Pan, Jibby E Kurichi, Zi Zhang, Debra Saliba, John T Henry-Sánchez, Joel Streim

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Geriatrics Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 3 pooled it
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 3 syntheses or guidelines pooled it, 156 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Margaret G StinemanDepartment of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. mstinema@exchange.upenn.edu
Dawei Xie
Qiang Pan
Jibby E Kurichi
Zi Zhang
Debra Saliba
John T Henry-Sánchez
Joel Streim
Cancer Research And Biostatistics · USCenter for Clinical Research (United States) · USHospital Regional de Concepción · CLRAND Corporation · USUniversity of Pennsylvania · USVeterans Health Administration · US

Funding

RESEARCH TRAINING IN NEUROLOGIC REHABILITATIONT32HD007425 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI SALCIDO, RICHARD · 1992 to 2011
$2.4M
Impairment Activity StagingR01AG032420 · NIA · UNIVERSITY OF PENNSYLVANIA · PI STINEMAN, MARGARET GRACE · 2009 to 2010
$686k
NIA NIH HHS AG032420-01A1NIA NIH HHS R01 AG032420NICHD NIH HHS T32 HD007425NICHD NIH HHS T32-HD-007425
6 · The paper itself

Abstract

objectivesTo examine the independent association between five stages of activities of daily living (ADLs) and mortality after accounting for known diagnostic and sociodemographic risk factors.

designFor five stages of ADLs (0 to IV), determined according to the severity and pattern of ADL limitations, unadjusted life expectancies and adjusted associations with mortality were estimated using a Cox proportional hazards regression model.

settingCommunity.

participantsNine thousand four hundred forty-seven participants aged 70 and older from the second Longitudinal Study of Aging. MEASUREMENTS: One-, 5-, and 10-year survival and time to death.

resultsMedian life expectancy was 10.6 years for participants with no ADL limitations and 6.5, 5.1, 3.8, and 1.6 years for those at ADL stages I, II, III, and IV, respectively. The sociodemographic- and diagnostic-adjusted hazard of death at 1 year was five times as great at stage IV as at stage 0 (hazard ratio = 5.6, 95% confidence interval = 3.8-8.3). The associations between ADL stage and mortality declined over time but remained statistically significant at 5 and 10 years.

conclusionADL stage continued to explain mortality risk after adjusting for known risk factors including advanced age, stroke, and cancer. ADL stages might aid clinical care planning and policy as a powerful prognostic indicator particularly of short-term mortality, improving on current ADL measures by profiling activity limitations of relevance to determining community support needs.

Indexed as

Activities of Daily LivingCause of DeathAgedAged, 80 and overFemaleGeriatric AssessmentHumansLife ExpectancyLongitudinal StudiesMaleMortalityProportional Hazards ModelsRisk FactorsSurvival RateUnited States

Identifiers

PMID22352414
PMCPMC3302958
OpenAlexW1997643388

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.